No committee data
Total trades
222
Latest filing
Jul 30, 2026TSM purchase
Hypothetical 30d alphaAverage excess return vs S&P 500 (SPY) 30 days after each purchase. Positive = outperformed SPY.
ProUnlock historical performance
Hypothetical 90d alphaAverage excess return vs S&P 500 (SPY) 90 days after each purchase. Positive = outperformed SPY.
ProUnlock historical performance
Top sector
TechnologyOther, Financials
Cleo Fields congressional trading snapshot
This page summarizes public STOCK Act disclosures associated with Cleo Fields. It connects the lawmaker profile to recent filings, related tickers, filing-delay context, and historical performance estimates without claiming motive or making investment recommendations.
Last updated
Jul 30, 2026
Data source
Public House and Senate STOCK Act disclosures normalized by Congressional Trader.
Key caveat
Public filings show reported transactions and value ranges. They do not prove intent, inside information, legality, or future returns.
Cleo Fields stock trading profile
Congressional Trader tracks 222 public disclosures for Cleo Fields, a D-LA member of the House. This profile combines filing dates, reported amount ranges, committee context, and post-trade performance signals in one searchable page.
The latest filing shown here was a purchase of TSM, filed on Jul 30, 2026. Frequently tracked tickers on this profile include AAPL, AMD, AMZN, ARM, AVGO, BMNR.
Cleo Fields stock trade questions
Use this profile as the canonical lawmaker hub before opening one-off ticker pages. It keeps purchases, sales, filing dates, tickers, and disclosure-delay context in one place.
What stocks did Cleo Fields buy?
Open the recent trade rows and related ticker links for AAPL, AMD, AMZN to separate purchases from sales.
How timely are the filings?
The latest visible disclosure delay is 20 days. Always compare transaction date against filing date.
Where is the full tracker?
Use the congressional stock trading tracker to compare this profile against the live disclosure feed, ticker pages, alerts, and leaderboard context.
Congressional stock trading trackerCleo Fields performance context
These metrics summarize historical public disclosures after normalization. They are useful for comparing patterns, but they do not represent a complete portfolio return or a real-time strategy a reader could have copied before the filing was public.
Trade count
222
Sample size for this profile.
30d win rate
Pro
Unlock the historical win rate.
30d avg alpha
Pro
Unlock benchmark-relative alpha.
Latest delay
20 days
Trade date to filing date.
Top tickers
AAPL, AMD, AMZN
Most visible ticker paths.
Recent trades
No committee data
No committee data
No committee data
No committee data
No committee data
No committee data
No committee data
No committee data
No committee data
No committee data
No committee data
No committee data
No committee data
No committee data
No committee data
No committee data
No committee data
No committee data
No committee data
No committee data
No committee data
No committee data
No committee data
No committee data
No committee data
No committee data
No committee data
No committee data
No committee data
No committee data
No committee data
No committee data
No committee data
No committee data
No committee data
No committee data
No committee data
No committee data
No committee data
No committee data
No committee data
No committee data
No committee data
No committee data
No committee data
No committee data
No committee data
No committee data
No committee data
FAQ
How many trades are tracked for Cleo Fields?
Congressional Trader currently tracks 222 stock disclosures for this lawmaker.
How do alerts work for this profile?
Save a lawmaker watch and Congressional Trader will match future public filings after they are collected. Pro email is post-publication, not real-time execution data.
What was the latest disclosure for Cleo Fields?
The latest tracked disclosure shown here is a purchase of TSM, filed on Jul 30, 2026.
How is performance measured for Cleo Fields?
The profile pairs tracked trade count with benchmark-relative alpha, win rate, ticker concentration, and disclosure delay. These are historical public-disclosure estimates, not a complete portfolio return.
What can this data say, and what can it not say?
It can show public filings, tickers, dates, and reported value ranges. It cannot prove intent, inside information, legality, or future investment performance.